Creative Planning Takeda Pharmaceutical CO LTD Transaction History

Creative Planning

$93.6 Billion
Q2 2024

A detailed history of Creative Planning transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Creative Planning holds 107,759 shares of TAK stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,759

Previous 145,128 25.75%

Holding current value

$1.57 Million

Previous $2.02 Million 30.82%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$12.6 - $13.67 $470,849 - $510,834	-37,369 Reduced 25.75%	107,759 $1.39 Million
Q1 2024 May 10, 2024	BUY	$13.89 - $15.04 $541,876 - $586,740	39,012 Added 36.76%	145,128 $2.02 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $252,196 - $291,272	-18,877 Reduced 15.1%	106,116 $1.51 Million
Q3 2023 Nov 16, 2023	SELL	$15.03 - $16.32 $29,323 - $31,840	-1,951 Reduced 1.54%	124,993 $1.93 Million
Q2 2023 Jul 21, 2023	BUY	$15.57 - $17.11 $432,347 - $475,110	27,768 Added 28.0%	126,944 $1.99 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $506,012 - $545,751	33,116 Added 50.13%	99,176 $1.63 Million
Q4 2022 Feb 10, 2023	SELL	$12.42 - $15.62 $15,897 - $19,993	-1,280 Reduced 1.9%	66,060 $1.03 Million
Q3 2022 Nov 03, 2022	BUY	$12.8 - $28.65 $320,729 - $717,883	25,057 Added 59.26%	67,340 $873,000
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $75,820 - $86,858	5,779 Added 15.83%	42,283 $594,000
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $71,531 - $81,094	5,283 Added 16.92%	36,504 $523,000
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $53,615 - $66,764	-4,071 Reduced 11.54%	31,221 $426,000
Q3 2021 Nov 10, 2021	BUY	$16.3 - $17.26 $47,155 - $49,933	2,893 Added 8.93%	35,292 $578,000
Q2 2021 Aug 04, 2021	SELL	$16.55 - $18.64 $188,107 - $211,862	-11,366 Reduced 25.97%	32,399 $545,000
Q1 2021 Apr 30, 2021	BUY	$16.71 - $19.9 $147,148 - $175,239	8,806 Added 25.19%	43,765 $799,000
Q4 2020 Jan 29, 2021	SELL	$15.39 - $18.97 $283,560 - $349,522	-18,425 Reduced 34.51%	34,959 $636,000
Q3 2020 Nov 05, 2020	BUY	$17.1 - $19.19 $142,733 - $160,178	8,347 Added 18.53%	53,384 $952,000
Q2 2020 Jul 23, 2020	SELL	$14.59 - $19.5 $53,793 - $71,896	-3,687 Reduced 7.57%	45,037 $808,000
Q1 2020 May 05, 2020	SELL	$13.02 - $20.31 $2,343 - $3,655	-180 Reduced 0.37%	48,724 $740,000
Q4 2019 Jan 30, 2020	SELL	$16.88 - $20.83 $49,272 - $60,802	-2,919 Reduced 5.63%	48,904 $965,000
Q3 2019 Nov 01, 2019	BUY	$16.15 - $17.99 $5,071 - $5,648	314 Added 0.61%	51,823 $891,000
Q2 2019 Jul 26, 2019	BUY	$16.58 - $20.49 $226,797 - $280,282	13,679 Added 36.16%	51,509 $912,000
Q1 2019 Apr 24, 2019	BUY	$16.7 - $21.52 $631,761 - $814,101	37,830 New	37,830 $771,000

Others Institutions Holding TAK

# of Institutions

318

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $45.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Takeda Pharmaceutical CO LTD Transaction History